期刊文献+

开环核苷类抗病毒药物的研究概况 被引量:2

A Survey of the Study of Antivirus Nucleoside Antiviral Drugs
下载PDF
导出
摘要 开环核苷类抗病毒药物具有低毒、低耐受性和广谱抗DNA病毒活性,其前药更是提高了药物的口服生物利用度。综述了几种常见开环核苷类药物及其前药近年的研究进展,在此基础上展望了抗病毒药物的研究方向。 Antivirus nucleoside antiviral drugs have low toxicity,low tolerance and broad-spectrum anti-DNA virus activity,and furthermore the prodrugs have improved the oral bioavailability.The research process of several common kinds of acyclic nucleoside drugs and the prodrugs in recent years was surveyed,and on this basis,the research direction of antiviral drugs was forcasted.
出处 《北京联合大学学报》 CAS 2010年第2期29-34,共6页 Journal of Beijing Union University
基金 山东省自然科学基金(Y2008B27) 山东省优秀中青年科学家科研奖励基金(2007BS04021)
关键词 开环核苷类药物 抗病毒 前药 acyclic nucleotides antivirus prodrug
  • 相关文献

参考文献40

  • 1石荣显.阿昔洛韦合成路线图解[J].中国医药工业杂志,1997,28(6):286-288. 被引量:3
  • 2吴宁苹,范淑玲,方文军,陆振宇.阿昔洛韦缓释片的工艺研究[J].中国现代应用药学,2004,21(4):276-278. 被引量:3
  • 3于巧玲..阿昔洛韦缓释微丸制备技术的研究[D].沈阳药科大学,2002:
  • 4蒋文勇,杨静,耿红梅,于黔,戴群.阿昔洛韦致急性肾功能衰竭12例临床分析[J].贵州医药,2009,33(6):541-542. 被引量:3
  • 5Bronson J J,Ismal G,Hitchcockm J,et al.Synthesis and antiviral activity of the nucleotide analog (S) -1-[3-hydroxy-2-(phosphonylmethoxy)propyl]cystosine[J].J Med Chem,1989,32 (7):1457-1463. 被引量:1
  • 6Bronson J J,Ferrara L M,Howell H G,et al.A new synthesis of the potent and selective anti-herpesvirus agent (S)-1-(3-hydroxy-2-(phosphonylmethoxy)propyl)cytosine[J].Nucleosides Nucleotides,1990,9(6):745-769. 被引量:1
  • 7Brodfuehrer P R,Howell H G,Sapinoc J R,et al.A practical synthesis of (S)-HPMPC[J].Tetrahedron Lett,1994,35(20):3243-3246. 被引量:1
  • 8Vemishetti P,Biochemistry P R,Howell H G.Process for the preparation of nucleotides:US,5591852[P].1995-01-07. 被引量:1
  • 9De Clercq E.S-Adenosylhomocysteinehy drolase inhibitors as broad spectrum antiviral agents[J].Biochem Pharmacol,1987(36):2567-2575. 被引量:1
  • 10Hadziyannis S J,Tassopoulos N C,Heathcote E J,et al.Adefovir dipivoxil for the treatment of hepatitis B e antigen-negative chronic hepatitis B[J].N Engl J Med,2003(348):800-807. 被引量:1

二级参考文献74

  • 1崔岚,安富荣,王晓珉.核苷酸逆转录酶抑制剂替诺福韦DF[J].中国新药杂志,2004,13(11):1054-1058. 被引量:30
  • 2候新朴,宁保明,李晓燕,谭安民.甲硝唑前体药物脂质体及微量量热法药效学研究[J].北京医科大学学报,1994,26(6):481-483. 被引量:3
  • 3刘晓辉,王琳,贯宝和,孔漫,张兴权,陶佩珍,陈鸿珊.9-(2-膦酰甲氧乙基)腺嘌呤及其位置异构体3-(2-膦酰甲氧乙基)腺嘌呤的合成和抗病毒活性研究[J].药学学报,1996,31(2):112-117. 被引量:4
  • 4TAN X L, CHU C K, BOUDINOT F D. Development and optimization of anti-HIV nucleoside analogs and prodrugs:a review of their cellular pharmacology, structureactivity relationships and pharmaookinetics[J ]. Adv Drug Deliv Rev, 1999, 39(2) : 117 - 151. 被引量:1
  • 5PARANG K, WIEBE L I, KNAUS E E. Novel approaches for designing 5'-O-ester prodrugs of 3'-azi- do-2', 3'-dideoxythymidine (AZT) [J ]. Curr Med Chem, 2000, 7(10) :995 - 1039. 被引量:1
  • 6MAZIASZ, TIMOTHY. Methods and compositions for the treatment or prevention of human immunodeficiency virus and related conditions using cyclooxy- genase-2 selective inhibitors and antiviral agents:US, 2005/026902 A1[P ]. 2005 - 02 - 03. 被引量:1
  • 7CAROLE A, GILLES Q, FLORENCE S, et al. New antiviral nueleoside prodrugs await application [ J ]. Curr Med Chem, 2003, 10(18) : 1825 - 1843. 被引量:1
  • 8ERIK D C, HUGH J F. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy[J]. Br J Pharmacol, 2006, 147 ( 1 ): 1-11. 被引量:1
  • 9LAVIE A, SCHLICHTING L, VE-TFER I R, et al. The bottleneck in AZT activation[ J ]. Nat Med, 1997, 3 (8) : 922 - 924. 被引量:1
  • 10NAESENS L, BALZARINI J, BISCHOFBERGER N, et al. Antiretroviral activity and pharmacokinetics in mice of oral his (pivaloyloxyrnethyl)-9-(2-phosphonylmethoxyethyl ) adenine, the bis (pivaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl ) adenine [ J ]. Antimicrob Agents Chemother, 1996, 40(1) :22 - 28. 被引量:1

共引文献38

同被引文献16

引证文献2

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部